63336-U

BIOshell lgG 1000 Å C4 (2.7 μm) HPLC Columns

L × I.D. 5 cm × 300 μm, HPLC Column

• Synonim(y): BIOshell IgG 1000 Å C4, 2.7 μm HPLC Column
• Kod UNSPSC: 41115709
• NACRES: SB.52

Właściwości

• product name: BIOshell lgG 1000 Å C4, 2.7 μm HPLC Column, column L × I.D. 5 cm × 300 μm
• Materiały: stainless steel hardware
• Poziom jakości: 100
• agency: suitable for USP L26
• opis: Shell thickness (0.5 μm); Solid core (1.7 μm)
• linia produktu: BIOshell
• Właściwości: endcapped
• opakowanie: pkg of 1 unit
• zakres etykietowania: 0.6% carbon loading
• Parametry: 90 °C max. temp.
• metody: HPLC: suitable
• kolumna dł. × śr. wewn.: 5 cm × 300 μm
• powierzchnia: 22 m²/g
• macierz: spherical silica particle platform
• grupa aktywna macierzy: C4 (butyl) phase
• wielkość cząstki: 2.7 μm
• wielkość porów: 1000 Å
• operating pH range: 2-9
• metoda separacji: reversed phase

Opis

Opis ogólny

BIOshell IgG 1000Å C4 is a high-speed, high-performance liquid chromatography column based on a new wide-pore (1000Å) Fused-Core^® particle design. The Fused-Core particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency due to the shallow diffusion paths in the 0.5-micron thin porous shell and the small overall particle size of 2.7-microns. The densely bonded, extensively endcapped dimethylbutyl stationary phase of BIOshell IgG 1000Å C4 provides a stable, reversed-phase packing that can be used for separating high molecular weight compounds such as proteins.

Zastosowanie

UHPLC Analysis of Trastuzumab on BIOshell IgG 1000 Å C4, 2.7 μm
UHPLC Analysis of IgG2 on BIOshell IgG 1000 Å C4, C18, and Diphenyl, 2.7 μm

Informacje prawne

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

This page may contain text that has been machine translated.